Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates Life Science Investing News
Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology Psychedelics Investing
Seelos Announces Second Postponement of its Annual Meeting of Stockholders Life Science Investing News
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024 Life Science Investing News
Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing Company News
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market Life Science Investing News
